Crude and adjusted ORs of 2 doses of IPTp-SP versus 3 or more doses
| Outcome variable | Unadjusted analysis | Adjusted analysis* | ||||
| cOR | 95% CI | P value | aOR | 95% CI | P value | |
| Maternal parasitemia | ||||||
| 2 doses | 2.08 | 1.14 to 3.81 | 0.02 | 1.56 | 0.84 to 2.93 | 0.16 |
| ≥3 doses | 1 | 1 | ||||
| Active placental infection | ||||||
| 2 doses | 1.96 | 1.01 to 3.81 | 0.05 | 1.45 | 0.73 to 2.89 | 0.29 |
| ≥3 doses | 1 | 1 | ||||
| Overall placental infection | ||||||
| 2 doses | 1.82 | 1.29 to 2.57 | 0.001 | 1.58 | 1.08 to 2.29 | 0.02 |
| ≥3 doses | 1 | 1 | ||||
| Maternal anaemia | ||||||
| 2 doses | 1.32 | 1.03 to 1.70 | 0.03 | 1.19 | 0.92 to 1.54 | 0.18 |
| ≥3 doses | 1 | 1 | ||||
| Low birth weight | ||||||
| 2 doses | 1.72 | 1.14 to 2.58 | 0.01 | 1.52 | 0.99 to 2.32 | 0.05 |
| ≥3 doses | 1 | 1 | ||||
*Adjusted for age, education, household SES, marital status, gravidity, ITN use, malaria treatment in past 2 weeks and malaria treatment during pregnancy.
aOR, adjusted OR; IPTp-SP, intermittent preventive treatment in pregnancy using sulfadoxine-pyrimethamine ; ITN, insecticide-treated bednet; SES, socioeconomic status.